Projects with publication Courses, meetings and presentations in 2018

Slides:



Advertisements
Similar presentations
EuroPa - Establishment of an European Network of Excellence Müller, M.(1), Neumann, H.(2), Jungraithmeier, T., Almann, F. J., Wagner, M., Smith, S. (1)
Advertisements

27 September, 2004 GEO Special Session on Governance Analysis of Comments on Governance of GEOSS International Cooperation Subgroup Co-Chairs Patricio.
Lecture 3 Validity of screening and diagnostic tests
European Certificate for Quality in Internationalisation Your Name.
PRE-CONFERENCE WORKSHOP FOR NEWCOMERS TO HPH May , Moscow Alberto Appicciafuoco Medical Director of Nuovo San Giovanni di Dio Hospital Florence,
1 Progress report: DISCONTOOLS Project Morgane Delavergne DISCONTOOLS Project Manager, September 22nd, 2009 Mirror Group Meeting Châtelain Hotel, Brussels.
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
March 2015 Inter-American Network for the Prevention of Violence and Crime.
Testing, Piloting and Evaluating RiskMAP Interventions Annette Stemhagen, DrPH, FISPE Vice President, Strategic Development Services.
Author: Cumurciuc Mihai Co-author:Silvia Ioana Morar Coordinator: Dr. Parvu Mirela.
Britt Wendelboe Danish Society for Patient Safety Work Package 4 BMJ - Paris April 10, 2014.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
African Centre for Statistics United Nations Economic Commission for Africa Civil Registration and Vital Statistics System in Africa- Towards enhanced.
OMERACT 8 PsA Module Proposal Submitted by: Dafna Gladman and Philip Mease.
GRAPPA Committee Reports and Outcome measures Dafna D. Gladman, MD, FRCPC Professor of Medicine, University of Toronto Director, PsA Program, University.
Can an evidence based coaching intervention improve outcomes for older people with congestive heart failure (CHF) and their informal caregivers within.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative An.
Metal Working Group Metals: conservation and Research - Brussels, October 2003 The ICOM-CC Metal Working Group as a promoter of research in metal.
Exploring the Natural History of Bone Marrow Oedema Lesions in
Fig 1: Skin thickening and sclerodactyly Fig 2: Digital tip ulcers
Rheumatic and Musculoskeletal Diseases Study Group
EULAR Study Group on Microcirculation in Rheumatic Diseases (SG MC/RD)
Mobility of Italian citizens in EU and Efta countries
EULAR nurses study group for REsearch and STrategy (REST)
EULAR Foot & Ankle Study Group
MUHC Innovation Model.
Musculoskeletal Health in Europe
ISARIC – INTERNATIONAL SEVERE ACUTE RESPIRATORY INFECTION CONSORTIUM
Daniela B. Friedman, University of South Carolina
FINAL Recommendations
EULAR nurses study group for REsearch and STrategy (REST)
EULAR Study Group on Microcirculation in Rheumatic Diseases (SG MC/RD) V. Smith*1, A. Herrick2, A. Sulli3 and M. Cutolo3 1Ghent University Hospital, University.
Find and Treat All Missing Persons with TB
Francesca Barone on behalf of Essential study group.
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Preventing VTE in hospitalised patients
EULAR Lupus Nephritis Trials Network Study Group 2017
EULAR Study Group: Public Health in Rheumatic and Musculoskeletal Diseases Suzanne M.M. Verstappen on behalf of the Study Group Who we are: What we.
EULAR Study Group for Collaborative Research
Diffuse Idiopathic Skeletal Hyperostosis (DISH) Study Group
Figure 3 Transcriptome studies performed in the target
EULAR Synovitis Study Group Chairs : JE Fonseca & BR Lauwerys
EULAR Study Group on patient education
EULAR Study Group on Osteoarthritis
EULAR Study Group on Registers and Observational Drug Studies (RODS)
(A) Proposed new ANA result interpretation algorithm that includes the anti-DFS70 results. (A) Proposed new ANA result interpretation algorithm that includes.
The International Consortium for Personalised Medicine
EULAR Psychology Study Group
EULAR Lupus Nephritis Trials Network Study Group
Efficacy end points: the percentage of patients achieving an improvement in American College of Rheumatology (ACR) of (A) 20% (ACR20), (B) 50% (ACR50)
Digital Health Literacy: A brief overview of the IC-Health project
COST and COST Actions Participation of Georgian researchers
Improvement in PROs, TJC, SJC and PGA at month 6 in patients achieving (A) ACR50, (B) CDAI LDA and (C) HAQ-DI
Additional efficacy outcomes for the 12-week study of Japanese patients with rheumatoid arthritis treated with baricitinib or placebo. Additional efficacy.
EULAR Study Group: Public Health in Rheumatic and Musculoskeletal Diseases Suzanne M.M. Verstappen on behalf of the Study Group Who we are: What we.
EULAR nurses study group for REsearch and STrategy (REST)
IO4 – Business Intervention Approaches
Synovial Biopsy in Patients with UPIA
The Study Group aims to:
EULAR Study group on patient education
EULAR Study Group on SLE
EULAR Lupus Nephritis Trials Network Study Group
EULAR Study Group for Collaborative Research
EULAR Study Group on Osteoarthritis
Cardiovascular disease risk assessment capture rates in the NOCAR project, evaluated across diagnosis groups and participating centre. Cardiovascular disease.
Increased numbers of LDGs in association with disease activity and low complement levels in patients with SLE. Numbers of LDGs were determined by flow.
Serial determinations of both anti-chromatin and anti-dsDNA antibodies in a patient who developed lupus nephropathy during the study period, showing that.
Presentation transcript:

Projects with publication Courses, meetings and presentations in 2018 EULAR Study Group on Microcirculation in Rheumatic Diseases (EULAR SG MC/RD) V. Smith*1, A. Herrick2, A. Sulli3 and M. Cutolo3 1Ghent University Hospital, University of Ghent, Belgium, 2University of Manchester, United Kingdom, 3University of Genova, Italy Who we are The EULAR SG MC/RD was accepted by the EULAR Executive committee in March 2014 and is being supervised by EULAR Committee on Investigative Rheumatology, currently chaired by Prof. X. Mariette. The study group first convened at EULAR 2014 consisting of 12 founding members (Chair: Prof. V. Smith; Co-Chairs: Prof. A. Herrick, Prof. M. Cutolo, Prof. A. Sulli and other founding members: Prof. Y. Allanore, Prof. O. Distler, Prof. N. Damjanov, Prof. U. Müller-Ladner, Dr. W. Hermann, Prof. I. Murat, Dr. V. Riccieri and Prof. AE. Voskuyl) and 28 in members (from which 11 of 5 non- European countries: USA, Brasil, South Africa, Turkey and Japan). Anno 2018 the number of members has risen to over 70 members (18 European and 16 non-European countries). Projects with publication SG MC/RD 1+12: As standardization of techniques to evaluate the microcirculation is one of the aims of the study group, a first activity was a multicenter study to assess the reliability of simple capillaroscopic definitions to evaluate morphologies of single capillaries. Smith V, et al. Rheumatology. 2016;55(5):883-90. With the aim to optimize the reliability simple capillaroscopic definitions to discern a normal from an abnormal morphology of single capillary a new criterion “convexity” of the tip of capillary as a condition to be classified as “normal” has been suggested and evaluated in the 7th EULAR course on capillaroscopy, held in Genova, 2016. This extra criterion resulted in an excellent reliability of the simple definition. Cutolo M, et al. Rheumatology. 2018;57:757-9. SG MC/RD 2+13: The evaluation of inter-rater reliability of microcirculatory flow evaluation Laser Speckle Contrast Analysis (LASCA) was piloted by two of the founding members, Lambrecht V. et al. Ann Rheum Dis. 2016;75(6):1263-1264. The intra- and inter-reliability of microcirculatory flow evaluation with LASCA in SSc patients was evaluated by a systematic literature review and an additional pilot study in 30 SSc patients and 30 health controls. Cutolo M, et al. Autoimmun Rev. 2018;17(8):775-80. SG MC/RD 3: A cross-sectional, international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud’s phEnomenon (SUNSHINE survey) has been performed in between 471 eligible physicians, Ingegnoli F, et al. Rheumatol Int. 2017;37(11):1879-90. SG MC/RD 5: A systematic review to assess the role of capillaroscopy in systemic lupus erythematosus and to propose correct terminology to define capillaroscopic parameters has been performed. Cutolo M, et al. Autoimmun Rev. 2018;17(4):344-52. SG MC/RD 10: The role of endothelial cells in SSc has been investigated through a comprehensive systematic literature review, Mostmans Y, et al. Autoimmun Rev. 2017;16(8):774-86. Courses, meetings and presentations in 2018 - EULAR 2018, Amsterdam (The Netherlands) Workshop on Capillaroscopy Lecture "The importance to differentiate normal from abnormal capillaroscopic images for an early diagnosis of disease” Lecture EULAR Projects in Investigative Rheumatology “Microcirculation in rheumatic diseases” EULAR SG MC/RD meeting - 8th EULAR course on Capillaroscopy, 2018, Genova (Italy) - ACR 2018, Chicago (USA) Study group on Capillaroscopy - 8th EUSTAR course on SSc, 2019, Nijmegen (The Netherlands) Aim of the study group The EULAR SG MC/RD aims to build an international network of expert centres and individuals to exchange knowledge within Europe and provide a platform on which the investigators can: 1. Study (micro)vascular mechanisms involved in the progression of rheumatic musculoskeletal diseases (RMD) with (micro)vascular involvement. 2. Develop natural history investigations operating across existing cohorts of European centres interested in the cooperation and implementation of diagnostic tools on microcirculation. 3. Identify through statistical analysis (based on large samples), models based on (micro)vascular assessment tools to predict disease progression and outcome. 4. Evaluate the microvascular effects of novel target strategies within specific RMD populations. Ongoing projects See EULAR website: https://www.eular.org/investigative_rheumatology_study_groups.cfm Contact point vanessa.smith@ugent.be